by • April 25, 2016 • No Comments
Buffalo’s The Jacobs Institute has set its sights on major the world in 3D printing for healthcare after signing a two-year deal with Stratasys.
The partnership is primarily concerned with replicating blood vessels in a human brain, which is an interesting premise, but it is the begin of a thing bigger.
The first goal is just to find new treatments for life-threatening aneurysms, but this appears a quite specific issue and this innovation can pretty have a wider application.
Building on past good results
A Stratasys printing device was utilized to replicate an aneurysm last year and the educational value it provided was tremendous. Ciprian Ionita, a research assistant professor in biomedical engineering and neurosurgery, claims this innovation may assist them test devices to shift all kinds of blockages in the vascular process.
This may, in the end, mean which strokes, blocked arteries and additional may be treated much less invasively. In the end, of course, the whole process may actually be replaced.
A $200,000 grant of the James H Cummings Foundation has assisted the institute buy a refurbished Objet 500 Connex3, which can use a variety of materials and colours in a single print job. This won’t create the final bioprints, but it can assist with the planning stages. It can in addition assist with training surgeons and educating other health professionals with additional accurate models.
Dr. Adnan H. Siddiqui, chief medical officer at Jacobs and vice chairman and professor of neurosurgery at UB, said: “The new materials and colors mean we can create highly sophisticated 3D anatomical replicas to accelerate product testing, research and high end training.”
Stratasys grew of humble beginnings
Stratasys is a global leader in the 3D printing world and was founded in 1988 when Scott Crump mixed plastic and wax to invent FDM in his kitchen. Working with The Jacobs Institute, as well as other global partners, may assist it steal a march in the medical bioprinting world.
It is set to revolutionise the way we live and the healthcare process, so equite company wants a piece of which action. Stratasys revealed the formation of its own medical subsection last year and is looking for partners to hustle the innovation to its limits in the real world.
Replicating tiny, fragile and rigorous blood vessels in the depths of tissues like the heart and brain has frustrated the 3D printing community for a while, although Carnegie Mellon university has created a relatively good resultsful prototype by printing within a hydrogel solution.
If Stratasys and The Jacobs Institute can crack this code, and so it is a massive leap forward for bioprinting and medicine in general. Its impact can be felt in the world of organ transplants, vascular treatment and much additional.
The city of Buffalo is keen to get behind this, too, as it has launched an initiative to bring life sciences to the downtown area. The Jacobs Institute, the Gates Vascular Institute and University of Buffalo’s Center for Translational Research are all houtilized on the Buffalo Niagara Medical Campus.
It is potentially the hub of a research centre which may lead the world and they obviously believe which 3D printing may be the missing link in the chain. Stratasys, meanwhile, can acquire invaluable engineering feedback and one of the world’s most medical teams to drive its innovation forward.
“We require to create strategic partnerships with device manufacturers. 3D printing is an area of growth, we are in the forefront of it, and we want to be seen as a go-to place in which space,” said Bill Maggio, Jacobs Institute chief executive officer. “This in addition leverages our strengths in neurosurgery and heart surgery.”
This partnership, and so, is a big deal. Some of the world’s finest minds can get the world’s finest equipment and the backing to manufacture it all work.
It is an interesting prospect. We can’t wait to see the results.
by admin • March 5, 2017
by admin • November 28, 2016
by admin • November 28, 2016